Interstitial Lung Disease Induced by Osimertinib for Epidermal Growth Factor Receptor (EGFR) T790M-positive Non-small Cell Lung Cancer

A 75-year-old man with stage IV lung adenocarcinoma was treated with osimertinib due to disease progression despite having been administered erlotinib. Both an epidermal growth factor receptor (EGFR) L858R mutation on exon 21 and a T790M mutation on exon 20 were detected in a specimen from a recurre...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Intern Med
Autors principals: Matsumoto, Yoshiya, Kawaguchi, Tomoya, Yamamoto, Norio, Sawa, Kenji, Yoshimoto, Naoki, Suzumura, Tomohiro, Watanabe, Tetsuya, Mitsuoka, Shigeki, Asai, Kazuhisa, Kimura, Tatsuo, Yoshimura, Naruo, Kuwae, Yuko, Hirata, Kazuto
Format: Artigo
Idioma:Inglês
Publicat: The Japanese Society of Internal Medicine 2017
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5635308/
https://ncbi.nlm.nih.gov/pubmed/28794368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.8467-16
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars